Diseases

icon picker
Hematologic Diseases

Diagnosis and Treatment of Common Hematologic Diseases

Immune-Mediated Hemolytic Anemia (IMHA)

Cause:
Primary - Any breed (Cocker Spaniel, Bichon, Poodle, Old English Sheepdog, Collie)
Secondary
Infectious - Anaplasma, Babesia, Mycoplasma, Heartworm
Drugs - sulfas, beta lactams, certain toxins
Other - neoplasia, inflammation (eg. pancreatitis), envenomation
Direct Hemolytic Anemia - zinc (some pennies, toys, diaper cream, dog tags), hypophosphatemia, onion and garlic, acetaminophen
Signalment and Clinical Signs:
Average age 2-7y, female > male
Clinical Signs
Physical Exam
1
Lethargy/Weakness Anorexia Collapse Vomiting/Diarrhea Dark urine (bilirubin/hemoglobinuria)
Pallor
Tachycardia/tachypnea
Enlarged spleen and liver (25-50%)
Icterus
Pigmenturia
Hemic murmur (with marked anemia, resolves)
There are no rows in this table
Diagnosis:
Minimum Database:
CBC: mod-marked regenerative anemia (<0.25-0.30L/L) +/- spherocytosis (80-90%)
Extravascular hemolysis (more common, less severe) → icteric serum/urine
Intravascular serum → hemolytic serum/urine
Biochemistry: ↑ ALT (mild), ↑ bilirubin (moderate)
Urinalysis: bilirubinuria/hemoglobinuria
Specific Tests:
Slide Agglutination Test - 1 drop EDTA blood + 1 to 4 drops NaCl
Coomb’s Test (90%)
Rule out secondary causes:
Infectious - 4dx, serology
Neoplasia - abdominal ultrasound, thoracic rads
Treatment:
Goals:
Stabilize - blood transfusion, IV fluids
Immunosuppression
Prevent complications (ie. thromboembolism/DIC) - up to 80% of IMHA patients
Immunosuppression:
Corticosteroids (#1)
Prednisone (2mg/kg PO q24h) or Dexamethasone (0.25mg/kg IV q24h)
Omeprazole (Oakpark)
+/- Adjunct Immunosuppressive
Cyclosporine (5mg/kg BID or 10mg/kg SID)
ADR: GI, alopecia, gingival hyperplasia, immunosuppression
Azathioprine (2mg/kg PO q24h)
ADR: GI, pancreatitis, liver toxicity, BM suppression (do not use in cat)
Mycophenolate
ADR: diarrhea but NO myelosuppression or hepatotoxicity
Luflenomide
Antithrombotics (EXCEPT if severe thrombocytopenia <30,000/uL):
Clopidogrel (2mg/kg PO q24h)
Low-dose aspirin
Heparin
Rivaroxaban
Monitoring:
Repeat CBC
Initially every 12-24 hours until stable to discharge/manage as outpatient
Weekly until anemia resolved then wean
Wean 1 immunosuppressive at a time
Decrease by 25-50% every 2-4 weeks if CBC stable
If Hct declined since previous recheck, return to previous dose + taper slower
Prognosis:
Relapse rate 30%
Guarded-poor prognosis for longterm survival
Most deaths/euthanasia within first 2 months due to ongoing disease, complications

Feline IMHA
Cause: most young + secondary (Mycoplasma haemofelis, Feline leukemia virus)
Diagnosis: lower Hct (average 0.12L/L), can be non-regenerative, spherocytes NOT detectable, most extravascular, most Coomb’s positive
Treatment:
Immunosuppression: Corticosteroid +/- Adjunct (Cyclosporine most common)
Treat underlying disease (eg. Doxycycline for M. haemofelis)
No antithrombotics (thromboembolic complications rare in cats)
Can take months to respond, may be transfusion-dependent for some time

Immune-Mediated Thrombocytopenia (IMT/ITP)

Cause:
Primary or Secondary (like IMHA)
Other ddx: BM disease/neoplasia, infection (Ehrlichia, Anaplasma), DIC, platelet clumping
Signalment and Clinical Signs:
Average age 2-7y, female > male
Clinical Signs/Physical Exam
1
Pallor
Epistaxis
Petechiation/Ecchymoses
Melena
May be BAR with vital parameters
There are no rows in this table
Diagnosis:
Minimum Database:
CBC: marked thrombocytopenia (<50,000/uL) + mod-marked normocytic normochromic anemia + NO spherocytosis
Biochemistry:
Urinalysis:
Specific Tests:
Blood Smear - <2 platelets per HPF (normal: >15-20/HPF)
Rule out secondary causes:
Infectious - 4dx, serology
Neoplasia - abdominal ultrasound, thoracic rads
Treatment:
Goals:
Stabilize - blood transfusion, IV fluids
Immunosuppression
Prevent complications (ie. GI hemorrhage) - Omeprazole + restrict activity
Immunosuppression:
Corticosteroids (#1) - >70% improve to 50-100,000/uL in 1 week
Prednisone (2mg/kg PO q24h) or Dexamethasone (0.25mg/kg IV q24h)
+/- Adjunct Immunosuppressive
Vincristine (single dose)
ADR: GI, myelosuppression/neutropenia, soft tissue necrosis (IV)
Prognosis:
Low mortality 10-15% Relapse rate 30%
Recurrence 9-40%

Want to print your doc?
This is not the way.
Try clicking the ⋯ next to your doc name or using a keyboard shortcut (
CtrlP
) instead.